Schedule 13D ownership disclosure
Oruka Therapeutics Inc
Security class unavailable · CUSIP: 687604108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-005943
- Form type
- SC 13D
- Filer
- Adage Capital Management, L.P.
- CIK
- CIK 1535978
- Filed
- Oct 22, 2024
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership